Tempus stock
The P2P Price™ is a per-security, model-derived indicative estimate, calculated daily from a time-decayed, volume-weighted blend of bids, asks, and matches.
Buy Tempus shares
Sign up to view historical trading trends and place an offer to buy shares. Join thousands of investors on the marketplace.
Buy sharesSell Tempus shares
Use the marketplace to understand the potential price of your shares. List anonymously and benefit from flat, transparent fees.
Sell sharesMarket activity
Stay informed of the latest listings and standing bids.
About Tempus
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Tempus last round details
Frequently asked questions
Tempus is a privately held company. Accredited and institutional investors seeking exposure to pre-IPO companies can invest through the marketplace — place a bid or accept a listing, subject to the company's transfer policy.
In most cases, yes. Because these are private securities, purchases are subject to accreditation and the company's right of first refusal and final approval.
If you hold shares, you may be able to sell them by finding a buyer on the marketplace. Your ability to sell always depends on the class of shares, holding period, and the company's transfer restrictions.
As a private company, Tempus has no public stock price. The P2P Price shown here is a model-derived indicative estimate; sign up to see the live order book — the actual bids and asks — and to trade.
The last known valuation is $8.9B, from its most recent primary funding round. Private valuations are indicative and not publicly quoted.
No. Tempus remains privately held and cannot be accessed on public exchanges. Accredited investors can access it on secondary marketplaces like this one before an IPO.
Nothing on this page is an offer to buy or sell, or a solicitation of an offer, any security. Pricing is indicative — generated from platform order activity, not an executable quote.